- Home
- HOV vs BBOT Comparison
HOV vs BBOT Comparison
Compare HOV & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOV | BBOT |
|---|---|---|
| Founded | 1959 | 2016 |
| Country | United States | United States |
| Employees | 1891 | 106 |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 645.8M | 705.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HOV | BBOT |
|---|---|---|
| Price | $122.02 | $7.77 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $97.00 | $24.00 |
| AVG Volume (30 Days) | 95.7K | ★ 352.4K |
| Earning Date | 05-19-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.96 | N/A |
| P/E Ratio | $17.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $90.79 | $7.00 |
| 52 Week High | $162.06 | $14.87 |
Technical Indicators
Market Signals| Indicator | HOV | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 61.65 | 44.15 |
| Support Level | $117.28 | N/A |
| Resistance Level | $127.22 | $9.50 |
| Average True Range (ATR) | 5.58 | 0.53 |
| MACD | 1.36 | -0.09 |
| Stochastic Oscillator | 79.68 | 35.11 |
Price Performance
Historical ComparisonAbout HOV Hovnanian Enterprises Inc.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.